5.29
-0.15 (-2.76%)
| Penutupan Terdahulu | 5.44 |
| Buka | 5.51 |
| Jumlah Dagangan | 596,609 |
| Purata Dagangan (3B) | 404,181 |
| Modal Pasaran | 137,924,048 |
| Harga / Jualan (P/S) | 2.96 |
| Harga / Buku (P/B) | 2.47 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Jul 2025 - 1 Aug 2025 |
| Margin Keuntungan | -116.91% |
| Margin Operasi (TTM) | -66.97% |
| EPS Cair (TTM) | -2.65 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 35.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 70.98% |
| Nisbah Semasa (MRQ) | 12.06 |
| Aliran Tunai Operasi (OCF TTM) | -39.14 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -20.93 M |
| Pulangan Atas Aset (ROA TTM) | -29.91% |
| Pulangan Atas Ekuiti (ROE TTM) | -81.58% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Menurun | Bercampur |
| Medical Devices (Global) | Menurun | Bercampur | |
| Stok | CVRx, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.13 |
|
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.90% |
| % Dimiliki oleh Institusi | 70.86% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 18.00 (Canaccord Genuity, 240.27%) | Beli |
| Median | 13.00 (145.75%) | |
| Rendah | 7.00 (JP Morgan, 32.33%) | Jual |
| Purata | 12.75 (141.02%) | |
| Jumlah | 3 Beli, 1 Jual | |
| Harga Purata @ Panggilan | 5.49 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 09 May 2025 | 7.00 (32.33%) | Jual | 4.77 |
| Piper Sandler | 09 May 2025 | 12.00 (126.84%) | Beli | 4.77 |
| Canaccord Genuity | 08 Apr 2025 | 18.00 (240.26%) | Beli | 6.20 |
| Lake Street | 08 Apr 2025 | 14.00 (164.65%) | Beli | 6.20 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 28 May 2025 | Pengumuman | CVRx to Present at the William Blair 45th Annual Growth Stock Conference |
| 08 May 2025 | Pengumuman | CVRx Reports First Quarter 2025 Financial and Operating Results |
| 24 Apr 2025 | Pengumuman | CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025 |
| 07 Apr 2025 | Pengumuman | CVRx Reports Preliminary First Quarter 2025 Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |